Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.
The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.
Health Catalyst has recently gained recognition with several achievements:
- VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
- MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
- Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
- Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.
Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.
Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.
For more information, visit the Health Catalyst Investor Relations page.
Health Catalyst (Nasdaq: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's executive team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will be present.
The company's presentation is scheduled for Wednesday, January 15, 2025, at 10:30 am PT. Investors and interested parties can access the webcast and presentation materials through Health Catalyst's investor relations website at https://ir.healthcatalyst.com.
Health Catalyst (HCAT) announced the launch of an AI-powered version of BluePrint Protect™, following their agreement to acquire Intraprise Health. The platform helps healthcare organizations screen cybersecurity risks through third parties. The new AI-powered capability automates vendor security assessments, evaluation, and risk tracking, making the process more efficient and cost-effective.
The platform received the highest rating in a KLAS Emerging Company Spotlight Report with A+ scores across multiple categories. Key features include automated risk workflows, enhanced risk visibility through intuitive dashboards, customizable solutions, and compatibility with third-party products.
Health Catalyst (HCAT) has announced its leadership team's participation in three major upcoming investor conferences in December 2024. The schedule includes appearances at:
- The Citi 2024 Global Healthcare Conference in Miami on December 3 at 2:30 pm ET
- The 7th Annual Evercore HealthCONx Conference in Miami on December 4 at 2:10 pm ET
- The 36th Annual Piper Sandler Healthcare Conference in New York on December 5 at 12:30 pm ET
Health Catalyst (Nasdaq: HCAT) announced its participation in the upcoming Stephens Annual Investment Conference in Nashville. The company's leadership team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will take part in a fireside chat scheduled for Wednesday, November 20, 2024, at 1:00 pm CT.
Health Catalyst (Nasdaq: HCAT) has signed a definitive agreement to acquire Intraprise Health, a top-rated cybersecurity provider. This strategic acquisition, expected to close in Q4 2024, aims to enhance Health Catalyst's cybersecurity and risk management offerings. Intraprise, recognized for its leading position in KLAS Research's 2024 Cybersecurity Survey, will integrate its end-to-end cybersecurity risk management platform with Health Catalyst's data and analytics technology. The merger is anticipated to improve healthcare data protection, enhance analytic capabilities, and support industry security standards. The acquisition is funded through a mix of cash and stock, with further details available in Health Catalyst's Form 8-K filed with the SEC on November 6, 2024.
Health Catalyst (Nasdaq: HCAT), a prominent provider of data and analytics technology for healthcare organizations, announced the appointment of Dr. Jill Hoggard Green to its Board of Directors and Compensation Committee, effective December 1, 2024. Dr. Green, former CEO of The Queen's Health Systems, brings 39 years of healthcare leadership experience. She has been recognized as one of Modern Healthcare's Top 25 COOs and Becker's Top 130 Women Leaders in Healthcare. Dr. Green has held significant roles at Mission Health, Peace Health, and Intermountain Healthcare. Her extensive background in patient care and healthcare management is expected to enhance Health Catalyst's mission of delivering data-informed healthcare improvements. CEO Dan Burton expressed excitement about her anticipated contributions to the company's growth and impact.
Health Catalyst (Nasdaq: HCAT) has partnered with CyncHealth, Iowa's statewide health information exchange (HIE), to enhance health data management. This collaboration will leverage Health Catalyst's Ninja Universe, a cloud-native platform, to improve the quality and timeliness of patient health information shared among healthcare providers. By utilizing Health Catalyst's data and analytics, CyncHealth aims to deliver more accurate and secure Continuity of Care Documents (CCDs), facilitating better-coordinated care. Dr. Jaime Bland, CEO of CyncHealth, highlighted the importance of this partnership in advancing healthcare interoperability in Iowa, while Dan Burton, CEO of Health Catalyst, emphasized the positive impact on patient and provider experiences statewide.
Health Catalyst (HCAT) reported Q3 2024 financial results with total revenue of $76.4 million, representing a 3% year-over-year growth. The company achieved an Adjusted EBITDA of $7.3 million, marking a 266% increase from the previous year. Gross profit improved by 10% to $27.8 million, with gross margin expanding to 36% from 34%. The company's net loss decreased by 33% to $14.7 million compared to the same period last year. Based on strong performance, Health Catalyst raised its Adjusted EBITDA guidance by $1 million for 2024, demonstrating commitment to financial discipline and profitable growth.
Health Catalyst (HCAT) has announced it will release its third quarter 2024 operating results on Wednesday, November 6, 2024, after market close. The company will host a conference call at 4:30 pm ET on the same day to review the results. U.S. participants can join by dialing 800-343-5172, while international participants can dial 203-518-9856, using conference ID 'HCATQ324'. A live audio webcast will be available at ir.healthcatalyst.com, with a replay accessible for approximately 90 days after the call.
Health Catalyst (Nasdaq: HCAT), a leading provider of data and analytics technology for healthcare organizations, has announced its participation in two upcoming investor conferences. The company's leadership team, including CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight, will be present at these events:
1. The Wells Fargo Healthcare Conference in Boston, featuring a fireside chat on September 4, 2024, at 1:30pm ET. A webcast link and presentation materials will be available at https://ir.healthcatalyst.com.
2. The Cantor Global Healthcare Conference in New York, including a fireside chat on September 17, 2024, at 8:00am ET.
These conferences provide an opportunity for investors to gain insights into Health Catalyst's operations and future prospects in the healthcare data and analytics sector.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
What does Health Catalyst, Inc. do?
What are the main segments of Health Catalyst's business?
What recent achievements has Health Catalyst made?
What is the adaptive data architecture?
How does Health Catalyst generate its revenue?
What is the Best in KLAS ranking?
What is the significance of the MeasureAble™ ONC-Health IT certification?
How does the acquisition of Carevive Systems benefit Health Catalyst?
How does Health Catalyst support its clients?
Where can I find more information about Health Catalyst's financial performance?
